Ovid Therapeutics Balance Sheet (2016-2026) | OVID

Balance Sheet Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)
212.20M201.78M187.80M166.67M72.81M58.26M42.01M60.71M71.62M57.44M27.04M29.45M28.66M15.02M26.30M21.14M20.74M20.48M12.64M94.06M
Short-term Investments (Quarter)
79.55M79.60M84.13M54.67M24.89M29.64M78.79M59.49M47.28M47.70M26.77M21.86M9.93M4.99M56.48M61.46M
Cash & Current Investments (Quarter)
212.20M201.78M187.80M166.67M152.37M137.86M126.15M115.37M96.52M87.07M105.83M88.94M75.94M62.71M53.08M43.00M30.67M25.48M69.12M155.52M
Receivables - Other (Quarter)
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)
3.71M3.28M2.68M2.42M2.72M2.64M2.38M1.80M5.65M4.64M3.76M2.91M3.92M3.12M2.87M2.92M3.74M3.22M4.73M4.62M
Current Assets (Quarter)
215.87M205.06M190.48M170.09M156.08M140.50M131.38M119.52M102.17M91.71M109.60M93.17M80.89M65.83M55.94M45.92M42.09M28.82M74.37M160.15M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
0.11M0.10M0.24M0.26M1.24M1.16M1.15M1.05M0.96M0.86M0.77M0.69M0.62M0.51M0.43M0.35M0.28M0.27M0.25M0.22M
Long-Term Investments (Quarter)
1.61M1.63M1.63M2.78M2.23M5.95M5.62M5.98M16.47M16.12M17.63M22.02M21.05M21.12M20.91M20.91M20.91M41.96M10.08M
Intangibles (Quarter)
0.23M0.20M0.26M0.24M
Goodwill & Intangibles (Quarter)
0.23M0.20M0.26M0.24M
Other Non-Current Assets (Quarter)
0.23M0.10M0.26M1.93M0.08M1.93M0.26M0.21M0.29M0.25M0.21M1.93M1.93M1.93M0.09M1.93M1.93M1.93M1.93M
Non-Current Assets (Quarter)
2.13M2.03M4.07M21.01M21.25M24.53M23.89M23.85M34.06M33.32M34.43M38.44M37.20M36.83M36.23M35.73M35.34M35.02M76.57M65.48M
Assets (Quarter)
218.00M207.09M194.54M191.10M177.33M165.03M155.27M143.37M136.23M125.03M144.03M131.61M118.09M102.65M92.17M81.65M77.43M63.85M150.93M225.63M
Liabilities
Current Liabilities
Accounts Payables (Quarter)
0.91M3.14M7.13M2.26M4.62M1.03M1.95M1.83M3.76M1.22M3.70M3.60M4.72M2.71M3.19M1.95M3.95M1.71M1.96M8.88M
Payables (Quarter)
0.91M3.14M7.13M2.26M4.62M1.03M1.95M1.83M3.76M1.22M3.70M3.60M4.72M2.71M3.19M1.95M3.95M1.71M1.96M8.88M
Accumulated Expenses (Quarter)
10.38M6.92M7.67M2.18M4.60M5.70M4.50M4.09M5.43M6.22M6.52M4.04M8.11M7.61M5.99M6.00M2.87M2.96M4.90M5.41M
Other Accumulated Expenses (Quarter)
1.96M0.12M0.55M0.14M
Short term Debt (Quarter)
Current Leases (Quarter)
0.53M0.80M0.94M1.22M1.25M1.27M1.29M1.31M1.34M1.36M1.38M1.41M1.43M1.46M
Current Deferred Revenue (Quarter)
0.72M0.72M
Total Current Liabilities (Quarter)
11.29M10.06M14.80M6.99M6.72M10.14M8.66M11.47M8.90M14.12M11.63M10.52M9.31M8.92M6.80M8.29M15.75M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)
15.87M15.97M16.25M16.00M15.70M15.39M15.07M14.76M14.43M14.10M13.76M13.42M13.07M12.71M12.35M11.99M11.61M
Total Non-Current Liabilities (Quarter)
11.29M10.06M14.80M26.10M
Total Liabilities (Quarter)
11.29M10.06M14.80M26.10M25.18M22.98M22.99M22.42M25.53M23.74M56.23M53.33M29.19M26.36M23.94M22.38M21.64M19.15M20.27M27.36M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)
206.71M197.02M179.75M165.00M152.15M142.05M132.27M120.95M110.70M101.29M87.80M78.28M88.90M76.29M68.23M59.28M55.79M44.70M130.66M198.27M
Shareholder's Equity (Quarter)
206.71M197.02M179.75M165.00M152.15M142.05M132.27M120.95M110.70M101.29M87.80M78.28M88.90M76.29M68.23M59.28M55.79M44.70M130.66M198.27M
Liabilities and Shareholders Equity (Quarter)
218.00M207.09M194.54M191.10M177.33M165.03M155.27M143.37M136.23M125.03M144.03M131.61M118.09M102.65M92.17M81.65M77.43M63.85M150.93M225.63M
Retained Earnings (Quarter)
-133.97M-145.36M-187.50M-0.09M-0.08M-0.04M-238.90M-251.30M-262.54M0.00M-289.60M-0.01M-295.05M-304.30M-0.05M-0.07M-331.40M-321.71M-338.70M
Preferred Shares (Quarter)
1.001.001.001.001.001.001.001.001.001.00
Treasury Shares (Quarter)
0.37M0.34M0.67M